Browse

You are looking at 71 - 80 of 307 items for :

  • Refine by Content Type: All x
Clear All Modify Search
Richard Lafayette

The SARS-CoV-2 virus that causes the disease COVID-19 reached pandemic status in short order and has changed everything in our world. Modern living has been turned upside down in pursuit of efforts to control spread of this virus, identify infected patients, and treat them appropriately. Economies are faltering. Epidemiologists and public health officials are doing their best to find ideal practices while governments impose what they feel are appropriate guidelines and restrictions on populations. How this will evolve and the size of its ultimate impact on our lives is yet to be seen, but it is already certain to have

Patients who develop acute kidney injury (AKI) after primary total hip arthroplasty (THA) are at increased risk for adverse outcomes, including complications and death, reports a study in Arthritis Research & Therapy.

On analysis of the US National Inpatient Sample from 1998 to 2014, the researchers identified a cohort of 4.1 million primary THAs. Of these, approximately 61,000 developed AKI: a rate of 1.5%. The primary outcome of interest was the rate of complications (including infection and revision arthroplasty) and mortality associated with AKI after THA. Healthcare utilization and transfusion were analyzed as secondary outcomes.

With adjustment for

Jorge Cerdá and Bonnie L. Freshly

Acute kidney injury (AKI) affects people of all ages, races, genders, ethnicities, and socioeconomic status across the world. For those persons, the stakes are high: in the most severe forms of AKI, the associated morbidity and mortality are higher than those of other common critical conditions, such as acute respiratory distress syndrome and septic shock.

Most commonly, AKI is first encountered by a variety of non-nephrology healthcare providers, including primary care physicians, pediatricians, intensive care unit and emergency department providers, surgeons, nurses, advanced care providers, pharmacists, trainees, hospital administrators, and quality control experts.

Despite the ubiquity of AKI and its

David McFadden

Anna has been providing home hemodialysis for 6 years to her husband, who has chronic kidney disease stage 4.

Initially, when the couple were given options for the available forms of dialysis treatment—in-center dialysis, peritoneal dialysis, and home hemodialysis—Anna was extremely reluctant to do home dialysis because she had no medical background. They ultimately decided on home hemodialysis, however, because of her husband’s work schedule.

Over the past 6 years, Anna has been a champion for home hemodialysis. Changes to Medicare reimbursement for telemedicine visits have enabled her husband to receive virtual nephrology visits at home, which keeps him from

Bridget M. Kuehn

The ASN is working closely with the US government to ensure the safety and health of the more than 37 million Americans living with kidney diseases during the COVID-19 pandemic.

On March 18, 2020, ASN President Anupam Agarwal, MD, FASN, and leaders from 15 other professional medical societies met by phone with President Donald Trump to stress the unique challenges of caring for patients during the pandemic. The more than 500,000 US patients on dialysis and the 222,000 with kidney transplants are among those most vulnerable to the spread of COVID-19.

Other leaders of the US COVID-19 response team participating

Gert Mayer

The COVID-19 situation in Austria is still developing. Looking at the numbers from Northern Italy, it replicates the pace there (increase in confirmed cases of 1.5 times each day). Tyrol is a “red zone”; everyone with typical symptoms is a suspected case. The government has taken rigorous actions, closing down borders and public life. People not needed for public service (like medical personnel) or other basic aspects of life (supermarket employees, etc.) are not allowed to leave home, with the exception of buying food.

Nephrology is a sensitive specialty because people with kidney diseases are very vulnerable. We have reduced

Jennifer Jones

The nephrologist’s voice sounded far away as he told me about my diagnosis. Membranoproliferative glomerulonephritis, type 1 idiopathic. My immune system had caused damage to my kidneys, and no one could tell me why.

I asked him if I could still serve in the Marine Corps.

“Oh, of course not,” he said matter-of-factly.

He was right. After serving almost 12 years as a combat camera videographer, I was medically retired. I lost more than a military career. I was in my 20s, single, and living alone away from my family. I felt like I no longer had an

Kidney News interviewed Katherine R. Tuttle, MD, FASN, FACP, FNKF, about her experience on the ground during the outbreak of COVID-19 in Washington state. Dr. Tuttle is executive director for research, Providence Health Care, professor of medicine, University of Washington, and co-principal Investigator, Institute of Translational Health Sciences, in Spokane, WA.

Washington state is the epicenter of the COVID-19 outbreak in the United States. What is the situation on the ground?

This is very serious. Every nephrologist here at Providence Health Care is essentially on-call 24/7. I am personally covering the Special Pathogen Unit (SPU) at Providence Sacred Heart

Michael Allon

In a matter of just a few weeks, COVID-19, a viral illness that none of us have previously heard of, has evolved into a global pandemic of a magnitude not encountered in over 100 years. As of March 20, 2020, there have been over 200,000 infections documented worldwide with nearly 9000 deaths. The number of infections in the US topped 14,000, and is expected to rise substantially as more tests are performed. Over 200 deaths have been reported.

COVID-19 has overwhelmed the healthcare systems in China, Korea, Italy, and Iran, and is growing in scope elsewhere at an alarming rate.

Terrence Jay (T.J.) O’Neill

How many of you have been here?

It’s 11 p.m. The 68-year-old lady just brought in by EMS is unresponsive on the gurney. Her BP is—well, it’s not good—and while you’re judiciously giving her IV fluids you’re wondering when it’s going to be pressor time. Many initial labs are still cooking, but the creatinine is 4.8 mg%. Her family is on the way in, but her daughter isn’t sure just what meds she is on, and anyway she thinks the PCP changed a couple of them at her mother’s visit last week. She just isn’t sure which ones. The voicemail